Cardiovascular and Metabolism
Metabolic disorders describes a large class of diseases, including heart disease and diabetes, that involve an imbalance in proteins, lipids, carbohydrates, or nucleic acids. Our current clinical program in metabolic diseases focuses on cardiovascular disease, the number one cause of morbidity and mortality in the United States and other developed countries.
Regeneron has investigational product candidates progressing through all stages of human clinical trials.
This section discusses pipeline drug candidates currently undergoing clinical testing in a variety of diseases. The safety and efficacy of these drug candidates have not been evaluated by any regulatory authorities for the indications described in this section.